Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
87.81
+0.71 (0.82%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Globus Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 11,877 | 11,685 | 11,262 | 7,343 | 7,415 | 7,326 | Upgrade
|
| Market Cap Growth | 7.56% | 3.76% | 53.38% | -0.97% | 1.22% | 13.84% | Upgrade
|
| Enterprise Value | 11,367 | 11,398 | 11,092 | 7,122 | 6,506 | 6,347 | Upgrade
|
| Last Close Price | 87.81 | 87.31 | 82.71 | 53.29 | 74.27 | 72.20 | Upgrade
|
| PE Ratio | 22.40 | 21.73 | 109.36 | 59.76 | 38.99 | 49.11 | Upgrade
|
| Forward PE | 19.69 | 21.59 | 25.54 | 20.76 | 32.74 | 33.48 | Upgrade
|
| PS Ratio | 4.04 | 3.98 | 4.47 | 4.68 | 7.25 | 7.65 | Upgrade
|
| PB Ratio | 2.59 | 2.56 | 2.70 | 1.84 | 4.02 | 4.21 | Upgrade
|
| P/TBV Ratio | 4.96 | 4.88 | 5.78 | 4.48 | 4.68 | 4.91 | Upgrade
|
| P/FCF Ratio | 20.17 | 19.85 | 27.79 | 44.44 | 71.01 | 33.40 | Upgrade
|
| P/OCF Ratio | 15.76 | 15.51 | 21.63 | 30.16 | 41.55 | 26.52 | Upgrade
|
| PEG Ratio | 2.05 | 1.51 | 1.82 | 1.81 | 2.71 | 3.26 | Upgrade
|
| EV/Sales Ratio | 3.87 | 3.88 | 4.40 | 4.54 | 6.36 | 6.62 | Upgrade
|
| EV/EBITDA Ratio | 12.96 | 13.00 | 15.97 | 17.00 | 21.30 | 23.97 | Upgrade
|
| EV/EBIT Ratio | 18.94 | 18.99 | 25.15 | 26.04 | 27.44 | 32.57 | Upgrade
|
| EV/FCF Ratio | 19.31 | 19.36 | 27.37 | 43.11 | 62.31 | 28.93 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.13 | 0.13 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.13 | 0.13 | 0.75 | 1.19 | 0.02 | - | Upgrade
|
| Debt / FCF Ratio | 0.20 | 0.20 | 1.33 | 3.16 | 0.06 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.11 | -0.11 | -0.10 | -0.02 | -0.51 | -0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.58 | -0.58 | -0.60 | -0.17 | -3.06 | -3.80 | Upgrade
|
| Net Debt / FCF Ratio | -0.87 | -0.87 | -1.03 | -0.44 | -8.96 | -4.58 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.49 | 0.44 | 0.51 | 0.53 | Upgrade
|
| Inventory Turnover | 1.32 | 1.32 | 1.09 | 0.83 | 0.98 | 1.03 | Upgrade
|
| Quick Ratio | 2.61 | 2.61 | 1.72 | 2.61 | 4.17 | 4.35 | Upgrade
|
| Current Ratio | 4.26 | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 | Upgrade
|
| Return on Equity (ROE) | 12.29% | 12.29% | 2.52% | 4.21% | 10.60% | 9.19% | Upgrade
|
| Return on Assets (ROA) | 7.11% | 7.11% | 5.33% | 4.77% | 7.35% | 6.70% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.91% | 13.41% | 9.61% | 7.51% | 13.69% | 13.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.50% | 12.50% | 10.00% | 5.80% | 12.40% | 10.70% | Upgrade
|
| Earnings Yield | 4.53% | 4.60% | 0.91% | 1.67% | 2.56% | 2.04% | Upgrade
|
| FCF Yield | 4.96% | 5.04% | 3.60% | 2.25% | 1.41% | 2.99% | Upgrade
|
| Buyback Yield / Dilution | 0.58% | 0.58% | -20.27% | -11.68% | 0.95% | -2.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.